Literature DB >> 14535653

Tumor escape from immune response: mechanisms and targets of activity.

Dmitry Gabrilovich1, Vladimir Pisarev.   

Abstract

Immune system plays an important role in control of tumor progression. Effective antitumor immune response depends on close interaction of several elements of immune system. They include antigen-presenting cells, different subsets of T cells, B cells and NK cells. However, tumor cells developed a number of mechanisms to escape recognition and elimination by immune system. In this review we will discuss these mechanisms and address possible approaches to correct them.

Entities:  

Mesh:

Year:  2003        PMID: 14535653     DOI: 10.2174/1389450033490849

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  26 in total

Review 1.  Cellular immunotherapy for soft tissue sarcomas.

Authors:  Steven Eric Finkelstein; Mayer Fishman; Anthony P Conley; Dmitry Gabrilovich; Scott Antonia; Alberto Chiappori
Journal:  Immunotherapy       Date:  2012-03       Impact factor: 4.196

Review 2.  Myeloid suppressor cells and immune modulation in lung cancer.

Authors:  Minu K Srivastava; Åsa Andersson; Li Zhu; Marni Harris-White; Jay M Lee; Steven Dubinett; Sherven Sharma
Journal:  Immunotherapy       Date:  2012-03       Impact factor: 4.196

3.  Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.

Authors:  Sadamu Homma; Hideo Komita; Yukiko Sagawa; Tsuneya Ohno; Gotaro Toda
Journal:  Immunology       Date:  2005-08       Impact factor: 7.397

4.  Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells.

Authors:  Sergei Kusmartsev; Srinivas Nagaraj; Dmitry I Gabrilovich
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

5.  Preoperative NLR for predicting survival rate after radical resection combined with adjuvant immunotherapy with CIK and postoperative chemotherapy in gastric cancer.

Authors:  Yingchun Li; Chenyu Wang; Mengdan Xu; Cuicui Kong; Aibing Qu; Meng Zhang; Zhichao Zheng; Guirong Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2017-01-20       Impact factor: 4.553

6.  Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?

Authors:  Pawel Kalinski; Howard Edington; Herbert J Zeh; Hideho Okada; Lisa H Butterfield; John M Kirkwood; David L Bartlett
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

7.  All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients.

Authors:  Noweeda Mirza; Mayer Fishman; Ingo Fricke; Mary Dunn; Anthony M Neuger; Timothy J Frost; Richard M Lush; Scott Antonia; Dmitry I Gabrilovich
Journal:  Cancer Res       Date:  2006-09-15       Impact factor: 12.701

Review 8.  Dendritic cells in immunotherapy of established cancer: Roles of signals 1, 2, 3 and 4.

Authors:  Pawel Kalinski
Journal:  Curr Opin Investig Drugs       Date:  2009-06

9.  Alteration of the immunological synapse in lung cancer: a microenvironmental approach.

Authors:  S Derniame; J-M Vignaud; G C Faure; M C Béné
Journal:  Clin Exp Immunol       Date:  2008-08-29       Impact factor: 4.330

Review 10.  Dendritic cell-based therapeutic cancer vaccines: what we have and what we need.

Authors:  Pawel Kalinski; Julie Urban; Rahul Narang; Erik Berk; Ewa Wieckowski; Ravikumar Muthuswamy
Journal:  Future Oncol       Date:  2009-04       Impact factor: 3.404

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.